Morgan Stanley’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Morgan Stanley’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,417	Closed	-$3K	–	7041
2015 Q3	$3K	Sell	7,417 -199,370	-96%	-$114K	﹤0.01%	6474
2015 Q2	$103K	Sell	206,787 -140,533	-40%	-$95.5K	﹤0.01%	5570
2015 Q1	$258K	Buy	347,320 +51,595	+17%	+$33.1K	﹤0.01%	5071
2014 Q4	$157K	Buy	295,725 +81,507	+38%	+$49.3K	﹤0.01%	5351
2014 Q3	$123K	Sell	214,218 -14,242	-6%	-$18K	﹤0.01%	5379
2014 Q2	$292K	Sell	228,460 -5,669	-2%	-$8.12K	﹤0.01%	4949
2014 Q1	$424K	Sell	234,129 -81,644	-26%	-$138K	﹤0.01%	4668
2013 Q4	$490K	Buy	315,773 +243,250	+335%	+$548K	﹤0.01%	4459
2013 Q3	$177K	Buy	72,523 +3,189	+5%	+$8.82K	﹤0.01%	4935
2013 Q2	$200K	Buy	+69,334	New	+$192K	﹤0.01%	4843

Other funds holding ONCY

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

KWMG

King Wealth Management Group Naples, Florida $914M AUM 24.3% 1-Year Est. Return

Credential Securities Vancouver $440M AUM 9.75% 1-Year Est. Return

Morgan Stanley's ONCY Position: Q4 2015 in Review

Morgan Stanley sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 7,417 shares — an estimated $3K sold.

Morgan Stanley first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $490K in Q4 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

Morgan Stanley reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
Morgan Stanley sold 7,417 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $3K.
Morgan Stanley first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
Morgan Stanley's ONCOLYTICS BIOTECH INC position peaked at $490K in Q4 2013.
7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Morgan Stanley's 13F filing for Q4 2015, filed 9 Feb 2016.